The pre-clinical study has confirmed that Regeneus’ osteoarthritis treatment Progenza is safe and prevents disease progression. It will now proceed with ethics application for the off-the-shelf stem cell therapy. This will lead to commencement of a clinical trial to assess its safety and preliminary efficacy.
